Amniotic Membrane Market by Type and Geography - Forecast and Analysis 2022-2028
SKU ID :TNV-14847972 | Published Date: 16-Dec-2019 | No. of pages: 145Description
TOC
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Cryopreserved amniotic membrane - Market size and forecast 2019-2024
• Dehydrated amniotic membrane - Market size and forecast 2019-2024
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Growing reimbursement coverage for new products
• Rise in development of new applications through research
• Industry consolidation through mergers and acquisitions
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Celularity Inc.
• Human Regenerative Technologies LLC
• Integra LifeSciences Holdings Corp.
• Katena Products Inc.
• MiMedx Group Inc.
• NuVision Biotherapies Ltd.
• Orthofix Medical Inc.
• Stryker Corp.
• Surgenex LLC
• TissueTech Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Type - Market share 2019-2024 (%)
Exhibit 19: Comparison by type
Exhibit 20: Cryopreserved amniotic membrane - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Cryopreserved amniotic membrane - Year-over-year growth 2020-2024 (%)
Exhibit 22: Dehydrated amniotic membrane - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Dehydrated amniotic membrane - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Celularity Inc. - Vendor overview
Exhibit 45: Celularity Inc. - Business segments
Exhibit 46: Celularity Inc. - Organizational developments
Exhibit 47: Celularity Inc. - Key customers
Exhibit 48: Human Regenerative Technologies LLC - Vendor overview
Exhibit 49: Human Regenerative Technologies LLC - Product segments
Exhibit 50: Human Regenerative Technologies LLC - Key offerings
Exhibit 51: Integra LifeSciences Holdings Corp. - Vendor overview
Exhibit 52: Integra LifeSciences Holdings Corp. - Business segments
Exhibit 53: Integra LifeSciences Holdings Corp. - Organizational developments
Exhibit 54: Integra LifeSciences Holdings Corp. - Geographic focus
Exhibit 55: Integra LifeSciences Holdings Corp. - Segment focus
Exhibit 56: Integra LifeSciences Holdings Corp. - Key offerings
Exhibit 57: Katena Products Inc. - Vendor overview
Exhibit 58: Katena Products Inc. - Product segments
Exhibit 59: Katena Products Inc. - Organizational developments
Exhibit 60: Katena Products Inc. - Key offerings
Exhibit 61: MiMedx Group Inc. - Vendor overview
Exhibit 62: MiMedx Group Inc. - Business segments
Exhibit 63: MiMedx Group Inc. - Organizational developments
Exhibit 64: MiMedx Group Inc. - Key offerings
Exhibit 65: NuVision Biotherapies Ltd. - Vendor overview
Exhibit 66: NuVision Biotherapies Ltd. - Business segments
Exhibit 67: NuVision Biotherapies Ltd. - Organizational developments
Exhibit 68: NuVision Biotherapies Ltd. - Key offerings
Exhibit 69: Orthofix Medical Inc. - Vendor overview
Exhibit 70: Orthofix Medical Inc. - Business segments
Exhibit 71: Orthofix Medical Inc. - Organizational developments
Exhibit 72: Orthofix Medical Inc. - Geographic focus
Exhibit 73: Orthofix Medical Inc. - Segment focus
Exhibit 74: Orthofix Medical Inc. - Key offerings
Exhibit 75: Stryker Corp. - Vendor overview
Exhibit 76: Stryker Corp. - Business segments
Exhibit 77: Stryker Corp. - Organizational developments
Exhibit 78: Stryker Corp. - Geographic focus
Exhibit 79: Stryker Corp. - Segment focus
Exhibit 80: Stryker Corp. - Key offerings
Exhibit 81: Surgenex LLC - Vendor overview
Exhibit 82: Surgenex LLC - Product segments
Exhibit 83: Surgenex LLC - Key offerings
Exhibit 84: TissueTech Inc. - Vendor overview
Exhibit 85: TissueTech Inc. - Business segments
Exhibit 86: TissueTech Inc. - Organizational developments
Exhibit 87: TissueTech Inc. - Key offerings
Exhibit 88: Validation techniques employed for market sizing
Exhibit 89: Definition of market positioning of vendors
Tables & Figures
Companies
Celularity Inc., Human Regenerative Technologies LLC, Integra LifeSciences Holdings Corp., Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc., Stryker Corp., Surgenex LLC, and TissueTech Inc.
- PRICE
-
$2500$4000